BlackRock
EXOZ

BlackRock’s eXoZymes Inc EXOZ Stock Holding History

BlackRock’s Portfolio EXOZ Stock Details EXOZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$81K Buy
9,610
+2,813
+41% +$26.5K ﹤0.01% 5054
2026
Q1 		$51K Buy
6,797
+546
+9% +$4.99K ﹤0.01% 5126
2025
Q4 		$68.1K Buy
6,251
+1,266
+25% +$17.5K ﹤0.01% 4983
2025
Q3 		$71.9K Buy
4,985
+144
+3% +$1.57K ﹤0.01% 4913
2025
Q2 		$47.8K Buy
4,841
+367
+8% +$4.48K ﹤0.01% 4996
2025
Q1 		$46.8K Buy
+4,474
New +$66.5K ﹤0.01% 4932

Other funds holding EXOZ

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DKCM
Davidson Kahn Capital Management Sherman Oaks, California $233M AUM 19.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

BlackRock's EXOZ Position: Q2 2026 in Review

BlackRock increased its eXoZymes Inc (EXOZ) stake by 41% in Q2 2026, buying an estimated $26.5K and bringing the position to 9,610 shares worth $81K. The position accounts for ﹤0.01% of the portfolio, ranked #5054.

BlackRock first reported a position in EXOZ in Q1 2025 and has held it in 6 quarters since. 9 funds tracked by Wall St. Rank hold EXOZ as of Q2 2026.

  • BlackRock held 9,610 shares of eXoZymes Inc worth $81K as of Q2 2026.
  • BlackRock bought 2,813 eXoZymes Inc shares in Q2 2026, an estimated $26.5K.
  • eXoZymes Inc made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #5054 holding.
  • BlackRock first reported a position in eXoZymes Inc in Q1 2025 and has held it in 6 quarters since.
  • 9 funds tracked by Wall St. Rank held eXoZymes Inc as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.